SARM1 base-exchange inhibitors induce SARM1 activation and neurodegeneration at low doses
Anisha Mani, Mateusz Mendel, Paul Westwood, Claudia Bonardi, Wiebke Saal, Andreas Topp, Matthew Bilyard, Alessandro Brigo, Matthias Wittwer, Jörg Benz, Bernd Kuhn, Ahmed Haider, Maude Giroud, James Keaney
This study shows that low doses of SARM1 base-exchange inhibitors paradoxically increase SARM1 activity and worsen neurodegeneration in vitro and in vivo.
npj Drug Discovery. · Jun 18, 2025Peer-reviewedNeuroscience